Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
|
CN |
Balance Sheet
Balance Sheet Decomposition
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
Balance Sheet
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
31
|
9
|
19
|
5
|
27
|
6
|
10
|
13
|
39
|
18
|
15
|
7
|
19
|
53
|
79
|
211
|
363
|
319
|
278
|
415
|
203
|
235
|
167
|
274
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
202
|
234
|
167
|
274
|
|
| Cash Equivalents |
31
|
9
|
19
|
5
|
27
|
6
|
10
|
13
|
39
|
18
|
15
|
7
|
19
|
53
|
79
|
210
|
363
|
318
|
278
|
414
|
1
|
1
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
262
|
263
|
18
|
7
|
0
|
0
|
0
|
1
|
1
|
|
| Total Receivables |
1 062
|
741
|
661
|
478
|
414
|
151
|
174
|
179
|
181
|
205
|
189
|
185
|
157
|
114
|
242
|
420
|
648
|
860
|
955
|
573
|
459
|
506
|
556
|
542
|
|
| Accounts Receivables |
402
|
134
|
130
|
99
|
100
|
114
|
128
|
143
|
142
|
144
|
132
|
138
|
90
|
43
|
122
|
252
|
419
|
637
|
740
|
435
|
351
|
424
|
497
|
500
|
|
| Other Receivables |
660
|
607
|
531
|
379
|
314
|
37
|
46
|
36
|
38
|
61
|
57
|
47
|
67
|
70
|
119
|
168
|
229
|
223
|
215
|
139
|
108
|
82
|
59
|
42
|
|
| Inventory |
119
|
87
|
50
|
16
|
43
|
284
|
278
|
280
|
279
|
276
|
282
|
290
|
289
|
299
|
375
|
433
|
415
|
440
|
409
|
435
|
385
|
381
|
369
|
382
|
|
| Other Current Assets |
39
|
58
|
16
|
21
|
45
|
36
|
37
|
35
|
28
|
30
|
24
|
36
|
47
|
5
|
25
|
41
|
38
|
63
|
38
|
106
|
106
|
115
|
18
|
11
|
|
| Total Current Assets |
1 251
|
895
|
745
|
521
|
529
|
477
|
497
|
506
|
527
|
529
|
511
|
517
|
512
|
471
|
737
|
1 366
|
1 727
|
1 699
|
1 687
|
1 529
|
1 152
|
1 238
|
1 111
|
1 210
|
|
| PP&E Net |
179
|
181
|
253
|
147
|
157
|
136
|
130
|
128
|
130
|
123
|
117
|
119
|
246
|
474
|
745
|
967
|
1 039
|
1 053
|
1 038
|
1 018
|
1 092
|
1 063
|
1 032
|
1 017
|
|
| PP&E Gross |
179
|
181
|
253
|
147
|
157
|
136
|
130
|
128
|
130
|
123
|
117
|
119
|
246
|
474
|
745
|
967
|
1 039
|
1 053
|
1 038
|
1 018
|
1 092
|
1 063
|
1 032
|
1 017
|
|
| Accumulated Depreciation |
71
|
83
|
95
|
85
|
97
|
87
|
99
|
111
|
123
|
132
|
143
|
149
|
151
|
160
|
65
|
105
|
148
|
202
|
250
|
296
|
336
|
390
|
443
|
491
|
|
| Intangible Assets |
39
|
38
|
34
|
21
|
22
|
183
|
177
|
172
|
166
|
161
|
164
|
159
|
189
|
184
|
262
|
402
|
388
|
416
|
402
|
390
|
386
|
377
|
374
|
374
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 764
|
2 002
|
2 002
|
2 058
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Long-Term Investments |
1
|
7
|
2
|
0
|
0
|
0
|
1
|
1
|
41
|
84
|
85
|
95
|
155
|
155
|
566
|
479
|
475
|
727
|
1 516
|
1 990
|
1 989
|
1 989
|
1 986
|
1 848
|
|
| Other Long-Term Assets |
0
|
410
|
407
|
403
|
399
|
4
|
4
|
4
|
5
|
6
|
4
|
6
|
5
|
3
|
84
|
88
|
95
|
44
|
52
|
48
|
20
|
15
|
15
|
33
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 764
|
2 002
|
2 002
|
2 058
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
1 469
N/A
|
1 531
+4%
|
1 441
-6%
|
1 091
-24%
|
1 107
+1%
|
800
-28%
|
809
+1%
|
812
+0%
|
869
+7%
|
903
+4%
|
880
-3%
|
895
+2%
|
1 107
+24%
|
1 286
+16%
|
4 156
+223%
|
5 304
+28%
|
5 727
+8%
|
5 997
+5%
|
4 698
-22%
|
4 977
+6%
|
4 641
-7%
|
4 685
+1%
|
4 519
-4%
|
4 484
-1%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
20
|
31
|
39
|
27
|
39
|
35
|
23
|
23
|
27
|
24
|
24
|
28
|
38
|
43
|
79
|
97
|
93
|
175
|
173
|
188
|
149
|
216
|
183
|
182
|
|
| Accrued Liabilities |
29
|
52
|
71
|
66
|
46
|
151
|
168
|
147
|
173
|
194
|
0
|
1
|
2
|
2
|
18
|
39
|
59
|
65
|
64
|
33
|
42
|
54
|
38
|
35
|
|
| Short-Term Debt |
925
|
904
|
890
|
849
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
34
|
0
|
10
|
150
|
435
|
155
|
130
|
125
|
42
|
31
|
138
|
263
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
35
|
75
|
92
|
104
|
250
|
163
|
1 623
|
202
|
11
|
1 603
|
|
| Other Current Liabilities |
20
|
53
|
85
|
112
|
100
|
83
|
69
|
75
|
72
|
76
|
236
|
234
|
391
|
351
|
1 535
|
234
|
202
|
270
|
288
|
255
|
172
|
169
|
202
|
73
|
|
| Total Current Liabilities |
993
|
1 040
|
1 085
|
1 054
|
185
|
269
|
260
|
245
|
273
|
294
|
260
|
263
|
465
|
396
|
1 677
|
595
|
881
|
770
|
905
|
764
|
2 028
|
672
|
572
|
2 157
|
|
| Long-Term Debt |
1
|
0
|
60
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
200
|
145
|
206
|
216
|
359
|
989
|
1 814
|
188
|
1 568
|
1 560
|
3
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
8
|
14
|
11
|
9
|
7
|
5
|
4
|
3
|
|
| Minority Interest |
3
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
38
|
36
|
35
|
34
|
33
|
32
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
876
|
13
|
13
|
13
|
13
|
13
|
13
|
13
|
27
|
30
|
87
|
330
|
203
|
107
|
127
|
85
|
79
|
72
|
65
|
66
|
|
| Total Liabilities |
997
N/A
|
1 042
+5%
|
1 147
+10%
|
1 054
-8%
|
1 062
+1%
|
282
-73%
|
273
-3%
|
258
-6%
|
285
+11%
|
307
+7%
|
273
-11%
|
275
+1%
|
492
+79%
|
626
+27%
|
1 909
+205%
|
1 181
-38%
|
1 346
+14%
|
1 285
-5%
|
2 067
+61%
|
2 706
+31%
|
2 334
-14%
|
2 348
+1%
|
2 202
-6%
|
2 228
+1%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
726
|
967
|
967
|
967
|
967
|
967
|
966
|
966
|
966
|
966
|
|
| Retained Earnings |
366
|
350
|
544
|
790
|
781
|
807
|
789
|
771
|
742
|
730
|
718
|
714
|
710
|
705
|
698
|
486
|
228
|
103
|
1 978
|
2 338
|
2 302
|
2 272
|
2 228
|
2 172
|
|
| Additional Paid In Capital |
389
|
389
|
389
|
416
|
416
|
876
|
876
|
876
|
876
|
876
|
876
|
885
|
876
|
916
|
2 219
|
3 642
|
3 642
|
3 642
|
3 642
|
3 642
|
3 642
|
3 642
|
3 579
|
3 579
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
39
|
39
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
119
|
|
| Total Equity |
472
N/A
|
489
+3%
|
294
-40%
|
37
-88%
|
45
+24%
|
518
+1 044%
|
537
+4%
|
554
+3%
|
584
+5%
|
596
+2%
|
607
+2%
|
620
+2%
|
615
-1%
|
660
+7%
|
2 246
+241%
|
4 123
+84%
|
4 381
+6%
|
4 712
+8%
|
2 631
-44%
|
2 271
-14%
|
2 307
+2%
|
2 337
+1%
|
2 318
-1%
|
2 255
-3%
|
|
| Total Liabilities & Equity |
1 469
N/A
|
1 531
+4%
|
1 441
-6%
|
1 091
-24%
|
1 107
+1%
|
800
-28%
|
809
+1%
|
812
+0%
|
869
+7%
|
903
+4%
|
880
-3%
|
895
+2%
|
1 107
+24%
|
1 286
+16%
|
4 156
+223%
|
5 304
+28%
|
5 727
+8%
|
5 997
+5%
|
4 698
-22%
|
4 977
+6%
|
4 641
-7%
|
4 685
+1%
|
4 519
-4%
|
4 484
-1%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
449
|
726
|
967
|
967
|
967
|
967
|
967
|
966
|
966
|
966
|
966
|
|